Koizumi Noriko, Sakamoto Yuji, Okumura Naoki, Tsuchiya Hideaki, Torii Ryuzo, Cooper Leanne J, Ban Yuriko, Tanioka Hidetoshi, Kinoshita Shigeru
Department of Biomedical Engineering, Faculty of Life and Medical Sciences, Doshisha University, Kyotanabe city, Japan.
Cornea. 2008 Sep;27 Suppl 1:S48-55. doi: 10.1097/ICO.0b013e31817f2298.
To review our attempt to devise a method of cultivated corneal endothelial transplantation using primates in which corneal endothelium, like that of humans, has low proliferative ability.
Monkey corneal endothelial cells (MCECs) were cultivated, with subcultures grown on collagen type I carriers. The corneal endothelia of 6 eyes of 6 monkeys were scraped intensively, after which cultivated MCEC sheets were inserted into the anterior chamber of 4 eyes. As controls, a collagen sheet without MCECs was transplanted in 1 eye of a monkey, and a suspension of cultivated MCECs was injected into the anterior chamber of 1 eye of another monkey.
MCECs produced a confluent monolayer of closely attached hexagonal cells, which expressed both ZO-1 and Na-K adenosine triphosphatase. Early postoperative period MCEC sheets were attached to Descemet membrane, and corneal clarity was recovered. Six months after transplantation, MCEC-transplanted corneas remained clear, and closely attached hexagonal cells were observed. In 1 animal with longer observation, polygonal cells were observed by in vivo specular microscopy at a density of >2000 cells/mm2 and remained >1600 cells/mm2 for < or =2 years. Control eyes showed irreversible bullous keratopathy throughout the observation period.
Cultivated MCECs become attached to the transplanted eye and maintain a clear cornea < or =2 years postoperatively, suggesting that corneal endothelial cells of primates might have proliferative ability in vivo once they have been cultured and proliferated in vitro. Our monkey model constitutes an important step forward for regenerative medicine with possible future application in patients with corneal endothelial dysfunction.
回顾我们尝试设计一种利用灵长类动物进行培养角膜内皮移植的方法,灵长类动物的角膜内皮与人类一样,增殖能力较低。
培养猴角膜内皮细胞(MCECs),并在I型胶原载体上进行传代培养。对6只猴子的6只眼睛的角膜内皮进行密集刮除,然后将培养的MCEC片植入4只眼睛的前房。作为对照,将不含MCECs的胶原片移植到1只猴子的眼睛中,并将培养的MCECs悬浮液注入另一只猴子的1只眼睛的前房。
MCECs产生了紧密附着的六边形细胞的汇合单层,这些细胞同时表达ZO-1和钠钾三磷酸腺苷酶。术后早期,MCEC片附着于Descemet膜,角膜清晰度恢复。移植后6个月,MCEC移植的角膜保持清晰,并观察到紧密附着的六边形细胞。在1只观察时间较长的动物中,通过活体镜面显微镜观察到多边形细胞,密度>2000个细胞/mm²,并且在≤2年的时间内保持>1600个细胞/mm²。对照眼在整个观察期内均表现为不可逆的大泡性角膜病变。
培养的MCECs附着于移植眼,并在术后≤2年维持角膜清晰,这表明灵长类动物的角膜内皮细胞一旦在体外培养和增殖,可能在体内具有增殖能力。我们的猴子模型是再生医学向前迈出的重要一步,未来可能应用于角膜内皮功能障碍患者。